Childhood cerebral adrenoleukodystrophy: MR perfusion measurements and their use in predicting clinical outcome after hematopoietic stem cell transplantation

American Journal of Neuroradiology

Volumn 37, Issue 9, 2016, Pages 1713-1720

  McKinney, A M ^a   Benson, J ^a   Nascene, D R ^a   Eisengart, J ^a   Salmela, M B ^a   Loes, D J ^b   Zhang, L ^a   Patel, K ^c   Raymond, G V ^a   Miller, W P ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Suburban Radiologic Consultants   (United States)

^c Radiology Assoc of the Fo Valley   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BRAIN REGION; CEREBRAL ADRENOLEUKODYSTROPHY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTELLIGENCE QUOTIENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; WHITE MATTER; BRAIN CIRCULATION; DIAGNOSTIC IMAGING; INTELLIGENCE TEST; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADRENOLEUKODYSTROPHY; CEREBROVASCULAR CIRCULATION; CHILD; CHILD, PRESCHOOL; CORPUS CALLOSUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTELLIGENCE TESTS; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WHITE MATTER;

EID: 84988411910     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4773     Document Type: Article

References (27)

1. Moser HW, Smith KD, Watkins PA, et al. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:3257-301
2. Bezman L, Moser HW. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet 1998;76:415-19 Medline
3. Melhem ER, Loes DJ, Georgiades CS, et al. X-linked adrenoleukodystrophy: The role of contrast-enhanced MR imaging in predicting disease progression. AJNR Am J Neuroradiol 2000;21:839-44 Medline
4. SchaumburgHH,Powers JM, Raine CS, et al. Adrenoleukodystrophy: A clinical and pathological study of 17 cases. Arch Neurol 1975;33:577-91 Medline
5. Powers JM, Pei Z, Heinzer AK, et al. Adreno-leukodystrophy: Oxidative stress of mice and men. J Neuropathol Exp Neurol 2005;64: 1067-79 CrossRef Medline
6. Shapiro E, Krivit W, Lockman L, et al. Long-term effect of bonemarrow transplantation for childhood onset cerebral X-linked adrenoleukodystrophy. Lancet 2000;356:713-18 CrossRef Medline
7. Peters C, Charnas LR, Tan Y, et al. Cerebral X-linked adrenoleukodystrophy: The international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104: 881-88 CrossRef Medline
8. Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: A scoring method for brainMRobservations. AJNRAmJ Neuroradiol 1994;15: 1761-66 Medline
9. Miller WP, Rothman SM, Nascene D, et al. Outcomes following allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: The largest single-institution cohort report. Blood 2011;118:1971-78 CrossRef Medline
10. Moser H, Raymond G, Koehler W, et al. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: Results of two concurrent trials. Adv Exp Med Biol 2003;544:369-87 CrossRef Medline
11. Loes DJ, Fatemi A, Melhem ER, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003;61:369-74 CrossRef Medline
12. Musolino PL, Rapalino O, Caruso P, et al. Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy. Brain 2012;135:2676-83 CrossRef Medline
13. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002;223:361-70 CrossRef Medline
14. Cha S, Lupo JM, Chen MH, et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibilityweighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078-84 CrossRef Medline
15. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: Dynamic contrast-enhanced T2-weighted MR imaging. Radiology 1999;211: 791-98 CrossRef Medline
16. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: Interobserver and intraobserver reproducibility study. Radiology 2002;224:797-803 CrossRef Medline
17. Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weightedMRimaging. AJNR Am J Neuroradiol 2005;26:825-30 Medline
18. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859-67 Medline
19. McKinney AM, Nascene D, Miller WP, et al. Childhood cerebral X-linked adrenoleukodystrophy: Diffusion tensor imaging measurements for prediction of clinical outcome after hematopoietic stem cell transplantation. AJNR Am J Neuroradiol 2013;34:641-49 CrossRef Medline
20. Wechsler D. Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV). San Antonio: Psychological Corporation; 2003
21. Riva D, Bova SM, Bruzzone MG. Neuropsychological testing may predict early progression of asymptomatic adrenoleukodystrophy. Neurology 2000;54:1651-55 CrossRef Medline
22. Cartier N, Aubourg P. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy. Brain Pathol 2010;20:857-62 CrossRef Medline
23. Eichler FS, Ren JQ, Cossoy M, et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 2008;63:729-42 CrossRef Medline
24. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326:818-23 CrossRef Medline
25. Kennedy DW, Abkowitz JL. Kinetics of central nervous system microglial and macrophage engraftment: Analysis using a transgenic bone marrow transplantation model. Blood 1997;9:986-93 Medline
26. Mildner A, Mack M, Schmidt H, et al. CCR2 + Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 2009;132:2487-500 CrossRef Medline
27. Miller WP, Mantovani LF, Muzic J, et al. Intensity of MRI gadolinium enhancement in cerebral adrenoleukodystrophy: A biomarker for inflammation and predictor of outcome following transplantation in higher risk patients. AJNR Am J Neuroradiol 2016;37:367-72 CrossRef Medline